# FingerMotion, Inc.: financial statements, quarterly

FNGR · Nasdaq · CIK 1602409 · [Technology](/sectors/technology.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/fngr.md) · [Financials](/companies/fngr/financials.md) · [Filings](/companies/fngr/filings.md) · [Insiders](/companies/fngr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fngr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.1](/filings/0001520138-25-000040.md) | [8.2 d](/filings/0001520138-25-000162.md) | [8.4](/filings/0001520138-25-000211.md) | [8.5](/filings/0001520138-25-000303.md) | [8.5](/filings/0001520138-26-000028.md) | [10.2 d](/filings/0001520138-26-000194.md) | [8.5](/filings/0001520138-26-000265.md) | [8.6](/filings/0001493152-26-047254.md) | [5.8](/filings/0001520138-26-000028.md) | [1.2 d](/filings/0001520138-26-000194.md) | [0.7](/filings/0001520138-26-000265.md) | [0.3](/filings/0001493152-26-047254.md) |
| Cost of revenue | $m | [5.5](/filings/0001520138-25-000040.md) | [7.5 d](/filings/0001520138-25-000162.md) | [7.7](/filings/0001520138-25-000211.md) | [8.2](/filings/0001520138-25-000303.md) | [8.1](/filings/0001520138-26-000028.md) | [8.9 d](/filings/0001520138-26-000194.md) | [8.3](/filings/0001520138-26-000265.md) | [8.6](/filings/0001493152-26-047254.md) | [5.5](/filings/0001520138-26-000028.md) | [1.0 d](/filings/0001520138-26-000194.md) | [0.4](/filings/0001520138-26-000265.md) | [0.1](/filings/0001493152-26-047254.md) |
| Gross profit | $m | [0.6](/filings/0001520138-25-000040.md) | [0.7 d](/filings/0001520138-25-000162.md) | [0.7](/filings/0001520138-25-000211.md) | [0.3](/filings/0001520138-25-000303.md) | [0.4](/filings/0001520138-26-000028.md) | [1.3 d](/filings/0001520138-26-000194.md) | [0.2](/filings/0001520138-26-000265.md) | [0.0](/filings/0001493152-26-047254.md) | [0.3](/filings/0001520138-26-000028.md) | [0.2 d](/filings/0001520138-26-000194.md) | [0.2](/filings/0001520138-26-000265.md) | [0.1](/filings/0001493152-26-047254.md) |
| Research and development | $m | [0.2](/filings/0001520138-25-000040.md) | [0.2 d](/filings/0001520138-25-000162.md) | [0.2](/filings/0001520138-25-000211.md) | [0.2](/filings/0001520138-25-000303.md) | [0.1](/filings/0001520138-26-000028.md) | [0.1 d](/filings/0001520138-26-000194.md) | [0.2](/filings/0001520138-26-000265.md) | [0.1](/filings/0001493152-26-047254.md) | [0.1](/filings/0001520138-26-000028.md) | [0.1 d](/filings/0001520138-26-000194.md) | [0.1](/filings/0001520138-26-000265.md) | [0.1](/filings/0001493152-26-047254.md) |
| Operating income | $m | [(2.0)](/filings/0001520138-25-000040.md) | [(0.5) d](/filings/0001520138-25-000162.md) | [(1.7)](/filings/0001520138-25-000211.md) | [(1.7)](/filings/0001520138-25-000303.md) | [(1.6)](/filings/0001520138-26-000028.md) | [(1.0) d](/filings/0001520138-26-000194.md) | [(2.0)](/filings/0001520138-26-000265.md) | [(1.5)](/filings/0001493152-26-047254.md) | [(1.7)](/filings/0001520138-26-000028.md) | [(1.8) d](/filings/0001520138-26-000194.md) | [(1.9)](/filings/0001520138-26-000265.md) | [(5.5)](/filings/0001493152-26-047254.md) |
| Interest expense | $m | [0.0 d](/filings/0001520138-24-000013.md) | [0.0 d](/filings/0001520138-24-000219.md) | not reported | [0.0](/filings/0001520138-24-000360.md) | [0.1](/filings/0001520138-26-000028.md) | [0.1 d](/filings/0001520138-26-000194.md) | [0.1](/filings/0001520138-26-000265.md) | [0.0](/filings/0001493152-26-047254.md) | [0.0](/filings/0001520138-26-000028.md) | [0.0 d](/filings/0001520138-26-000194.md) | [0.1](/filings/0001520138-26-000265.md) | [0.0](/filings/0001493152-26-047254.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001520138-26-000028.md) | [(0.9) d](/filings/0001520138-26-000194.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(1.9)](/filings/0001520138-25-000040.md) | [(0.5) d](/filings/0001520138-25-000162.md) | [(1.7)](/filings/0001520138-25-000211.md) | [(1.7)](/filings/0001520138-25-000303.md) | [(1.7)](/filings/0001520138-26-000028.md) | [(0.1) d](/filings/0001520138-26-000194.md) | [(2.0)](/filings/0001520138-26-000265.md) | [(1.5)](/filings/0001493152-26-047254.md) | [(1.7)](/filings/0001520138-26-000028.md) | [(1.8) d](/filings/0001520138-26-000194.md) | [(2.0)](/filings/0001520138-26-000265.md) | [(4.9)](/filings/0001493152-26-047254.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001520138-25-000040.md) | not reported | [(0.03)](/filings/0001520138-25-000211.md) | [(0.03)](/filings/0001520138-25-000303.md) | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.04)](/filings/0001520138-26-000265.md) | [(0.03)](/filings/0001493152-26-047254.md) | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.03)](/filings/0001520138-26-000265.md) | [(0.08)](/filings/0001493152-26-047254.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001520138-25-000040.md) | not reported | [(0.03)](/filings/0001520138-25-000211.md) | [(0.03)](/filings/0001520138-25-000303.md) | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.04)](/filings/0001520138-26-000265.md) | [(0.03)](/filings/0001493152-26-047254.md) | [(0.03)](/filings/0001520138-26-000028.md) | not reported | [(0.03)](/filings/0001520138-26-000265.md) | [(0.08)](/filings/0001493152-26-047254.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.9](/filings/0001520138-24-000013.md) | [1.5](/filings/0001520138-25-000162.md) | [1.1](/filings/0001520138-24-000232.md) | [0.8](/filings/0001520138-24-000360.md) | [0.2](/filings/0001520138-25-000040.md) | [1.1](/filings/0001520138-26-000194.md) | [2.9](/filings/0001520138-25-000211.md) | [0.2](/filings/0001520138-25-000303.md) | [0.0](/filings/0001520138-26-000028.md) | [0.1](/filings/0001493152-26-047254.md) | [1.0](/filings/0001520138-26-000265.md) | [2.1](/filings/0001493152-26-047254.md) |
| Current assets | $m | [17.4](/filings/0001520138-24-000013.md) | [18.4](/filings/0001520138-25-000162.md) | [26.0](/filings/0001520138-24-000232.md) | [29.9](/filings/0001520138-24-000360.md) | [31.7](/filings/0001520138-25-000040.md) | [42.0](/filings/0001520138-26-000194.md) | [48.9](/filings/0001520138-25-000211.md) | [45.1](/filings/0001520138-25-000303.md) | [51.0](/filings/0001520138-26-000028.md) | [51.8](/filings/0001493152-26-047254.md) | [52.9](/filings/0001520138-26-000265.md) | [53.1](/filings/0001493152-26-047254.md) |
| Total assets | $m | [17.6](/filings/0001520138-24-000013.md) | [18.4](/filings/0001520138-25-000162.md) | [26.3](/filings/0001520138-24-000232.md) | [30.2](/filings/0001520138-24-000360.md) | [31.9](/filings/0001520138-25-000040.md) | [48.8](/filings/0001520138-26-000194.md) | [55.7](/filings/0001520138-25-000211.md) | [51.9](/filings/0001520138-25-000303.md) | [60.1](/filings/0001520138-26-000028.md) | [60.8](/filings/0001493152-26-047254.md) | [61.9](/filings/0001520138-26-000265.md) | [62.7](/filings/0001493152-26-047254.md) |
| Current liabilities | $m | [4.9](/filings/0001520138-24-000013.md) | [6.8](/filings/0001520138-25-000162.md) | [15.3](/filings/0001520138-24-000232.md) | [20.2](/filings/0001520138-24-000360.md) | [22.3](/filings/0001520138-25-000040.md) | [35.1](/filings/0001520138-26-000194.md) | [39.5](/filings/0001520138-25-000211.md) | [36.8](/filings/0001520138-25-000303.md) | [43.7](/filings/0001520138-26-000028.md) | [45.7](/filings/0001493152-26-047254.md) | [48.6](/filings/0001520138-26-000265.md) | [51.3](/filings/0001493152-26-047254.md) |
| Total liabilities | $m | [4.9](/filings/0001520138-24-000013.md) | [6.8](/filings/0001520138-25-000162.md) | [15.4](/filings/0001520138-24-000232.md) | [20.3](/filings/0001520138-24-000360.md) | [22.4](/filings/0001520138-25-000040.md) | [35.2](/filings/0001520138-26-000194.md) | [39.5](/filings/0001520138-25-000211.md) | [36.8](/filings/0001520138-25-000303.md) | [43.7](/filings/0001520138-26-000028.md) | [45.7](/filings/0001493152-26-047254.md) | [48.6](/filings/0001520138-26-000265.md) | [51.5](/filings/0001493152-26-047254.md) |
| Current portion of debt | $m | [5.3](/filings/0001520138-24-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [12.6](/filings/0001520138-24-000013.md) | [11.7](/filings/0001520138-25-000162.md) | [10.9](/filings/0001520138-24-000232.md) | [9.9](/filings/0001520138-24-000360.md) | [9.6](/filings/0001520138-25-000040.md) | [13.7](/filings/0001520138-26-000194.md) | [16.2](/filings/0001520138-25-000211.md) | [15.1](/filings/0001520138-25-000303.md) | [16.4](/filings/0001520138-26-000028.md) | [15.2](/filings/0001493152-26-047254.md) | [13.4](/filings/0001520138-26-000265.md) | [11.3](/filings/0001493152-26-047254.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,079) d](/filings/0001520138-25-000040.md) | [(374) d](/filings/0001520138-25-000162.md) | [(1,410)](/filings/0001520138-25-000211.md) | [(1,494) d](/filings/0001520138-25-000303.md) | [(1,683) d](/filings/0001520138-26-000028.md) | [(3,592) d](/filings/0001520138-26-000194.md) | [(1,204)](/filings/0001520138-26-000265.md) | [(1,882) d](/filings/0001493152-26-047254.md) | [(548) d](/filings/0001520138-26-000028.md) | [(270) d](/filings/0001520138-26-000194.md) | [(2,346)](/filings/0001520138-26-000265.md) | [(1,145) d](/filings/0001493152-26-047254.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001520138-25-000040.md) | [(0.0) d](/filings/0001520138-25-000162.md) | not reported | not reported | [(0.0) d](/filings/0001520138-26-000028.md) | [2.4 d](/filings/0001520138-26-000194.md) | [1.8](/filings/0001520138-26-000265.md) | [0.0 d](/filings/0001493152-26-047254.md) | [18.3 d](/filings/0001520138-26-000028.md) | [0.1 d](/filings/0001520138-26-000194.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2023 (2022-11-30) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.7](/filings/0001520138-24-000013.md) | [51.5](/filings/0001520138-24-000232.md) | [52.1](/filings/0001520138-24-000360.md) | [52.5](/filings/0001520138-25-000040.md) | [52.7](/filings/0001520138-25-000211.md) | [52.7](/filings/0001520138-25-000303.md) | [53.3](/filings/0001520138-26-000028.md) | [57.3](/filings/0001520138-26-000265.md) | [59.4](/filings/0001493152-26-047254.md) | [60.5](/filings/0001520138-26-000028.md) | [61.3](/filings/0001520138-26-000265.md) | [63.0](/filings/0001493152-26-047254.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,871,297 at 2026-10-13, from the cover of the [10-Q filed 2026-10-15](/filings/0001493152-26-047254.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.